Floatz logo

VINCRISTINE SULFATE

B Cell Lymphoma

The First Affiliated Hospital of Soochow UniversitySmall moleculePhase 4 / ApprovedActive
BB
71/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
65/ 100
Competitive Position
81/ 100

Competitive context

21 Active assets in the B Cell Lymphoma cohort.

Asset / SponsorPhaseRating
Zanubrutinib
The First Affiliated Hospital of Soochow University
Phase 4BBB
Chimeric Antigen Receptor Modified T Cells Infusion
The First Affiliated Hospital of Soochow University
Phase 2/3BB
Cart-19 And 20 Cells
Henan Cancer Hospital
Phase 2BB
Cart-19 Cells
Shenzhen BinDeBio Ltd.
Phase 2/3BB
Sonrotoclax
BeOne Medicines
Phase 3B

View all 50 →

Same molecule, other indications

VINCRISTINE SULFATE is also rated in:

B-cell childhood acute lymphoblastic leukemiaDormant
A
Indicative ·
81 / 100
View asset →
diffuse large B-cell lymphomaDormant
A
Indicative ·
80 / 100
View asset →
Burkitt lymphomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →